RxDoctor Payments Data

Kirt Beus, MD

Otolaryngology · Provo, UTNPI 1396765871

Payments from drug & device makers

What this record shows

23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.0% of the total. Reporting peaked in 2019 at $1,017 and has fallen 75.0% since, to $255 in 2025.

$2,030in general payments, 2019–2025

Across 54 payments — averaging $37.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$852
  • Regeneron Healthcare Solutions, Inc.$165
  • Intersect ENT, Inc.$128
  • Pulse Biosciences, Inc.$128
  • Optinose US, Inc.$120
  • GSK$100
  • plus $537 from 17 others

What the payments were for

  • Travel & lodging$85242%
  • Food & beverage$1,17858%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,030 in reported general payments places this provider in the 65th percentile of 104 otolaryngology providers in Utah.

See all otolaryngology providers in Utah

Medicare billing

Part B allowed, 2024
$88,899
Medicare patients
142
Services billed
620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$46,569
Ipratropium Bromide33$1,016
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav57$599
Mupirocin30$432
Fluticasone Propionate30$296
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$171
Ondansetron Hcl37$166
Clarithromycin12$166

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →